{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:07:54Z","timestamp":1778602074618,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer US","isbn-type":[{"value":"9781071650912","type":"print"},{"value":"9781071650929","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5092-9_15","type":"book-chapter","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T01:08:17Z","timestamp":1767316097000},"page":"227-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methods for Probing NK Cell Surveillance of Antigen Presentation"],"prefix":"10.1007","author":[{"given":"Kamila","family":"Kr\u00f3l","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doriana","family":"Fruci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","volume":"11","author":"H-G Ljunggren","year":"1990","unstructured":"Ljunggren H-G, K\u00e4rre K (1990) In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition. Immunol Today 11:237\u2013244. https:\/\/doi.org\/10.1016\/0167-5699(90)90097-S","journal-title":"Immunol Today"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225\u2013274. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115526","journal-title":"Annu Rev Immunol"},{"key":"15_CR3","doi-asserted-by":"publisher","unstructured":"Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E, Bertaina A, Moretta F, Del Zotto G, Pietra G, Mingari MC, Locatelli F, Moretta L (2019) Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.01179","DOI":"10.3389\/fimmu.2019.01179"},{"issue":"9","key":"15_CR4","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M, Ishitani A, Navarro F, L\u00f3pez-Botet M, Geraghty DE (1998a) HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci 95(9):5199\u20135204. https:\/\/doi.org\/10.1073\/pnas.95.9.5199","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2012.00335","volume":"3","author":"K Krzewski","year":"2012","unstructured":"Krzewski K, Coligan JE (2012) Human NK cell lytic granules and regulation of their exocytosis. Front Immunol 3:335. https:\/\/doi.org\/10.3389\/fimmu.2012.00335","journal-title":"Front Immunol"},{"issue":"9","key":"15_CR6","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.4049\/jimmunol.1701500","volume":"200","author":"LA Gwalani","year":"2018","unstructured":"Gwalani LA, Orange JS (2018) Single Degranulations in NK cells can mediate target cell killing. J Immunol 200(9):3231\u20133243. https:\/\/doi.org\/10.4049\/jimmunol.1701500","journal-title":"J Immunol"},{"issue":"5","key":"15_CR7","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-10-3326","volume":"71","author":"L Cifaldi","year":"2011","unstructured":"Cifaldi L, Lo Monaco E, Forloni M, Giorda E, Lorenzi S, Petrini S, Tremante E, Pende D, Locatelli F, Giacomini P, Fruci D (2011) Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. Cancer Res 71(5):1597\u20131606. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3326","journal-title":"Cancer Res"},{"issue":"5","key":"15_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1158\/0008-5472.CAN-14-1643","volume":"75","author":"L Cifaldi","year":"2015","unstructured":"Cifaldi L, Romania P, Falco M, Lorenzi S, Meazza R, Petrini S, Andreani M, Pende D, Locatelli F, Fruci D (2015) ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors. Cancer Res 75(5):824\u2013834. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1643","journal-title":"Cancer Res"},{"issue":"1","key":"15_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/imr.12315","volume":"267","author":"J Das","year":"2015","unstructured":"Das J, Khakoo SI (2015) NK cells: tuned by peptide? Immunol Rev 267(1):214\u2013227. https:\/\/doi.org\/10.1111\/imr.12315","journal-title":"Immunol Rev"},{"issue":"5","key":"15_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.100964","volume":"24","author":"M Nikopaschou","year":"2025","unstructured":"Nikopaschou M, Samiotaki M, Stylianaki E-A, Kr\u00f3l K, Gragera P, Raja A, Aidinis V, Chroni A, Fruci D, Panayotou G, Stratikos E (2025) ERAP1 activity modulates the Immunopeptidome but also affects the proteome, metabolism, and stress responses in cancer cells. Mol Cell Proteomics 24(5):100964. https:\/\/doi.org\/10.1016\/j.mcpro.2025.100964","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"15_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03180-y","volume":"43","author":"P Tempora","year":"2024","unstructured":"Tempora P, D\u2019Amico S, Gragera P, Damiani V, Krol K, Scaldaferri V, Pandey K, Chung S, Lucarini V, Giorda E, Scarsella M, Volpe G, Pezzullo M, De Stefanis C, D\u2019Oria V, De Angelis L, Giovannoni R, De Ioris MA, Melaiu O, Purcell AW, Locatelli F, Fruci D (2024) Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma. J Exp Clin Cancer Res 43(1):292. https:\/\/doi.org\/10.1186\/s13046-024-03180-y","journal-title":"J Exp Clin Cancer Res"},{"key":"15_CR12","doi-asserted-by":"publisher","unstructured":"Tsao H-W, Anderson S, Finn KJ, Perera JJ, Pass LF, Schneider EM, Jiang A, Fetterman R, Chuong CL, Kozuma K, Stickler MM, Creixell M, Klaeger S, Phulphagar KM, Rachimi S, Verzani EK, Olsson N, Dubrot J, Pech MF, Silkworth W, Lane-Reticker SK, Allen PM, Ibrahim K, Knudsen NH, Cheng AY, Long AH, Ebrahimi-Nik H, Kim SY, Du PP, Iracheta-Vellve A, Robitschek EJ, Suermondt JSMT, Davis TGR, Wolfe CH, Atluri T, Olander KE, Rush JS, Sundberg TB, McAllister FE, Abelin JG, Firestone A, Stokoe D, Carr SA, Harding FA, Yates KB, Manguso RT (2024) Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint. Immunity 0(0). https:\/\/doi.org\/10.1016\/j.immuni.2024.10.013","DOI":"10.1016\/j.immuni.2024.10.013"},{"issue":"1","key":"15_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(00)80952-6","volume":"96","author":"A Lanzavecchia","year":"1999","unstructured":"Lanzavecchia A, Iezzi G, Viola A (1999) From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 96(1):1\u20134. https:\/\/doi.org\/10.1016\/S0092-8674(00)80952-6","journal-title":"Cell"},{"issue":"2","key":"15_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1012356108","volume":"108","author":"A De Maria","year":"2011","unstructured":"De Maria A, Bozzano F, Cantoni C, Moretta L (2011) Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-\u03b3 on activation. Proc Natl Acad Sci 108(2):728\u2013732. https:\/\/doi.org\/10.1073\/pnas.1012356108","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"15_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","volume":"19","author":"N Shimasaki","year":"2020","unstructured":"Shimasaki N, Jain A, Campana D (2020) NK cells for cancer immunotherapy. Nat Rev Drug Discov 19(3):200\u2013218. https:\/\/doi.org\/10.1038\/s41573-019-0052-1","journal-title":"Nat Rev Drug Discov"},{"issue":"1\u20132","key":"15_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294(1\u20132):15\u201322. https:\/\/doi.org\/10.1016\/j.jim.2004.08.008","journal-title":"J Immunol Methods"},{"issue":"2","key":"15_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","volume":"254","author":"E Aktas","year":"2009","unstructured":"Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G (2009) Relationship between CD107a expression and cytotoxic activity. Cell Immunol 254(2):149\u2013154. https:\/\/doi.org\/10.1016\/j.cellimm.2008.08.007","journal-title":"Cell Immunol"},{"issue":"3","key":"15_CR18","first-page":"406","volume":"24","author":"MJ Robertson","year":"1996","unstructured":"Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24(3):406\u2013415","journal-title":"Exp Hematol"},{"issue":"27","key":"15_CR19","doi-asserted-by":"publisher","first-page":"10346","DOI":"10.1073\/pnas.0604236103","volume":"103","author":"X Chen","year":"2006","unstructured":"Chen X, Allan DSJ, Krzewski K, Ge B, Kopcow H, Strominger JL (2006) CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc Natl Acad Sci 103(27):10346\u201310351. https:\/\/doi.org\/10.1073\/pnas.0604236103","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"15_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.immuni.2008.07.014","volume":"29","author":"ME Peterson","year":"2008","unstructured":"Peterson ME, Long EO (2008) Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29(4):578\u2013588. https:\/\/doi.org\/10.1016\/j.immuni.2008.07.014","journal-title":"Immunity"},{"issue":"2","key":"15_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4049\/jimmunol.1402542","volume":"194","author":"PM Saunders","year":"2015","unstructured":"Saunders PM, Vivian JP, Baschuk N, Beddoe T, Widjaja J, O\u2019Connor GM, Hitchen C, Pymm P, Andrews DM, Gras S, McVicar DW, Rossjohn J, Brooks AG (2015) The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope. J Immunol 194(2):781\u2013789. https:\/\/doi.org\/10.4049\/jimmunol.1402542","journal-title":"J Immunol"},{"key":"15_CR22","doi-asserted-by":"publisher","unstructured":"Sim MJW, Malaker SA, Khan A, Stowell JM, Shabanowitz J, Peterson ME, Rajagopalan S, Hunt DF, Altmann DM, Long EO, Boyton RJ (2017) Canonical and cross-reactive binding of NK cell inhibitory receptors to HLA-C Allotypes is dictated by peptides bound to HLA-C. Front Immunol 8. https:\/\/doi.org\/10.3389\/fimmu.2017.00193","DOI":"10.3389\/fimmu.2017.00193"}],"container-title":["Methods in Molecular Biology","Antigen Processing and Presentation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5092-9_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:08:44Z","timestamp":1778598524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5092-9_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650912","9781071650929"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5092-9_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 January 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}